Skip to main content

Yan Ming's Form 4 filing

Cytek Biosciences, Inc. (CTKB) · filed Aug 21, 2023

Accession no.
0001209191-23-046824
Filed
Aug 21, 2023
Trade date
Aug 18-21, 2023
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $161.4K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Yan MingCIK 0001874041Director, Officer (Chief Technology Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 18, 2023Common StockMOption exerciseAcquired+1,981––7,832,239Direct
Aug 18, 2023Common StockFTax withholdingDisposed−772$8.46−$6,531.127,831,467Direct
Aug 18, 2023Common StockMOption exerciseAcquired+7,363––7,838,830Direct
Aug 18, 2023Common StockFTax withholdingDisposed−2,868$8.46−$24,263.287,835,962Direct
Aug 21, 2023Common StockSSaleDisposed−20,000$8.07−$161,4007,815,962Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 18, 2023Common StockMOption exerciseDisposed−1,981$0.00$019,161Direct
Aug 18, 2023Common StockMOption exerciseDisposed−7,363$0.00$0105,542Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)